| Dr Mary Ann Defrance, MD | |
|
2140 53rd Ave, Bettendorf, IA 52722-6279 | |
| (563) 421-5700 | |
| Not Available |
| Full Name | Dr Mary Ann Defrance |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 4 Years |
| Location | 2140 53rd Ave, Bettendorf, Iowa |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184244584 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD-49121 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Genesis Medical Center-davenport | Davenport, IA | Hospital |
| Genesis Hlth System Dba Genesis Mdl Ctr-illini | Silvis, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Genesis Health System | 7214841436 | 184 |
News Archive
Mass producing human pluripotent stem cells (hPSCs), including embryonic stem cells and induced pluripotent stem cells, for regenerative medicine and drug discovery may have gotten much easier, thanks to a polymer-based 3D culture system developed by Japanese researchers.
A little more than a decade ago, researchers discovered that all cells secrete tiny communications modules jammed with an entire work crew of messages for other cells. Today, a team of researchers, led by stem cell researcher Raj Kishore, PhD, Director of the Stem Cell Therapy Program at the Center for Translational Medicine at Temple University School of Medicine, is harnessing the communications vesicles excreted by stem cells and using them to induce the damaged heart to repair itself.
Fewer than 10% of people who experience sudden cardiac arrest (SCA) outside of a hospital survive. Reoccurrence rates after an initial event are high, which is why current Canadian Cardiovascular Society, as well as other international guidelines, strongly recommend the use of implantable cardioverter defibrillators (ICDs) in selected patients who survive cardiac arrest.
A pilot study of guanfacine, a controlled-release alpha2-agonist, in children and adolescents with general, separation-related, and social anxiety disorder showed the drug to be safe and well-tolerated and provided preliminary evidence of its potential effectiveness.
› Verified 4 days ago
| Entity Name | Genesis Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477654945 PECOS PAC ID: 7214841436 Enrollment ID: O20031113000044 |
News Archive
Mass producing human pluripotent stem cells (hPSCs), including embryonic stem cells and induced pluripotent stem cells, for regenerative medicine and drug discovery may have gotten much easier, thanks to a polymer-based 3D culture system developed by Japanese researchers.
A little more than a decade ago, researchers discovered that all cells secrete tiny communications modules jammed with an entire work crew of messages for other cells. Today, a team of researchers, led by stem cell researcher Raj Kishore, PhD, Director of the Stem Cell Therapy Program at the Center for Translational Medicine at Temple University School of Medicine, is harnessing the communications vesicles excreted by stem cells and using them to induce the damaged heart to repair itself.
Fewer than 10% of people who experience sudden cardiac arrest (SCA) outside of a hospital survive. Reoccurrence rates after an initial event are high, which is why current Canadian Cardiovascular Society, as well as other international guidelines, strongly recommend the use of implantable cardioverter defibrillators (ICDs) in selected patients who survive cardiac arrest.
A pilot study of guanfacine, a controlled-release alpha2-agonist, in children and adolescents with general, separation-related, and social anxiety disorder showed the drug to be safe and well-tolerated and provided preliminary evidence of its potential effectiveness.
› Verified 4 days ago
| Entity Name | Genesis Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528616901 PECOS PAC ID: 6103829338 Enrollment ID: O20191031002622 |
News Archive
Mass producing human pluripotent stem cells (hPSCs), including embryonic stem cells and induced pluripotent stem cells, for regenerative medicine and drug discovery may have gotten much easier, thanks to a polymer-based 3D culture system developed by Japanese researchers.
A little more than a decade ago, researchers discovered that all cells secrete tiny communications modules jammed with an entire work crew of messages for other cells. Today, a team of researchers, led by stem cell researcher Raj Kishore, PhD, Director of the Stem Cell Therapy Program at the Center for Translational Medicine at Temple University School of Medicine, is harnessing the communications vesicles excreted by stem cells and using them to induce the damaged heart to repair itself.
Fewer than 10% of people who experience sudden cardiac arrest (SCA) outside of a hospital survive. Reoccurrence rates after an initial event are high, which is why current Canadian Cardiovascular Society, as well as other international guidelines, strongly recommend the use of implantable cardioverter defibrillators (ICDs) in selected patients who survive cardiac arrest.
A pilot study of guanfacine, a controlled-release alpha2-agonist, in children and adolescents with general, separation-related, and social anxiety disorder showed the drug to be safe and well-tolerated and provided preliminary evidence of its potential effectiveness.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mary Ann Defrance, MD 2140 53rd Ave, Bettendorf, IA 52722-6279 Ph: (563) 421-5700 | Dr Mary Ann Defrance, MD 2140 53rd Ave, Bettendorf, IA 52722-6279 Ph: (563) 421-5700 |
News Archive
Mass producing human pluripotent stem cells (hPSCs), including embryonic stem cells and induced pluripotent stem cells, for regenerative medicine and drug discovery may have gotten much easier, thanks to a polymer-based 3D culture system developed by Japanese researchers.
A little more than a decade ago, researchers discovered that all cells secrete tiny communications modules jammed with an entire work crew of messages for other cells. Today, a team of researchers, led by stem cell researcher Raj Kishore, PhD, Director of the Stem Cell Therapy Program at the Center for Translational Medicine at Temple University School of Medicine, is harnessing the communications vesicles excreted by stem cells and using them to induce the damaged heart to repair itself.
Fewer than 10% of people who experience sudden cardiac arrest (SCA) outside of a hospital survive. Reoccurrence rates after an initial event are high, which is why current Canadian Cardiovascular Society, as well as other international guidelines, strongly recommend the use of implantable cardioverter defibrillators (ICDs) in selected patients who survive cardiac arrest.
A pilot study of guanfacine, a controlled-release alpha2-agonist, in children and adolescents with general, separation-related, and social anxiety disorder showed the drug to be safe and well-tolerated and provided preliminary evidence of its potential effectiveness.
› Verified 4 days ago
Dr. Jasmin R Cabrera, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3740 Utica Ridge Rd, Suite B, Bettendorf, IA 52722 Phone: 563-344-7400 Fax: 563-359-9395 | |
Dr. Daniel J Arnold, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4480 Utica Ridge Rd Ste 160, Bettendorf, IA 52722 Phone: 563-742-4850 Fax: 563-742-4855 | |
Dr. Michael J Gimbel Ii, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 4017 Devils Glen Rd, Ste 100, Bettendorf, IA 52722 Phone: 563-332-6387 Fax: 563-332-9197 | |
Christopher M Crome, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2140 53rd Ave, Bettendorf, IA 52722 Phone: 563-421-5700 Fax: 563-421-5839 | |
Emmett Lee Wallace, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1019 Broadlawn Avenue, Bettendorf, IA 52722 Phone: 563-359-1181 Fax: 563-386-3177 | |
Sara Glassgow, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 2730 Crow Creek Rd, Bettendorf, IA 52722 Phone: 954-399-4673 Fax: 815-454-2832 |